Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05027971 · ClinicalTrials.gov registry record

Flexiva Pulse Registry

A clinical trial, sponsored by Boston Scientific Corporation.

Completed
Registry status
201
Enrollment target

NCT05027971 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 201 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05027971 has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
201 participants
Enrollment target

Study Summary

To obtain post-market safety and efficacy data for FlexivaTM Pulse High Power Single-Use Laser Fibers during lithotripsy and soft tissue procedure of holmium laser enucleation of the prostate (HoLEP).

Interventions

  • DEVICE Flexiva Pulse High Power Single-Use Laser Fibers

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2021-11-01
Est. Completion 2023-10-31

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT05027971

The ClinicalTrials.gov registry entry for NCT05027971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Flexiva Pulse High Power Single-Use Laser Fibers is the first listed.

NCT05027971 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05027971 about?

NCT05027971 is a clinical study titled "Flexiva Pulse Registry". To obtain post-market safety and efficacy data for FlexivaTM Pulse High Power Single-Use Laser Fibers during lithotripsy and soft tissue procedure of holmium laser enucleation of the prostate (HoLEP).

What is the current status of trial NCT05027971?

This trial is currently completed. The enrollment target is 201 participants. The study started on 2021-11-01. Estimated completion is 2023-10-31.

What interventions are being tested in trial NCT05027971?

The interventions under investigation include: Flexiva Pulse High Power Single-Use Laser Fibers (DEVICE).

Who is sponsoring clinical trial NCT05027971?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.